First up is Alnylam-partnered RNAi candidate fitusiran, an antithrombin-targeting agent ... While Sanofi is looking at using a lower dose to try to reduce the risk, there were still two cases ...
2) Novo Nordisk's CagriSema (cagrilintide and semaglutide), a fixed-dose combination of an amylin ... works by inhibiting SerpinPC1 mRNA, reducing antithrombin levels, promoting thrombin ...
Currently, there is no monotherapy for DIC. Various agents had been tried without success such as heparin, antithrombin III, recombinant tissue factor pathway inhibitor, recombinant activated protein ...
The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...
After more than 70 years of effective clinical use, heparin remains the most common anticoagulant in use and one of the most commonly prescribed drugs to hospitalized patients. However, the ...
and fewer laboratory tests and heparin dosage changes. Our results provide additional support for the growing sentiment that the anti-Xa HA is a superior test for monitoring UFH. On the basis of ...
Pediatric doses associated with consistent exposure across age are still unknown. Therefore, we aim to identify a dosing strategy for ivermectin treatment in both pre-school-aged children (2–5 years ...
Besides its anticoagulant bioactivity, Zhao group isolated low-molecular-weight polyguluronate sulfate (LPGS) from alginate and administered LPGS at dose-levels ranging from 12.5 to 100 mg/kg on rats, ...
Within the categorical baseline covariates, the authors showed that the better efficacy of standard-dose DOACs over warfarin was mainly driven by the results in patients with no history of previous ...
After hours: February 3 at 5:37:30 p.m. EST ...
These side effects may be common or severe. There is insufficient scientific evidence to establish a safe or effective dose of DMAE. Always speak with a healthcare provider before taking a supplement ...